TerrAscend Corp. is a North American cannabis company with vertically integrated operations in Pennsylvania, New Jersey, Maryland, and California, alongside retail operations in Ohio and Ontario, Canada. The company cultivates, processes, and sells medical and adult-use cannabis products, including flower, vaporizables, concentrates, topicals, tinctures, and edibles. It operates under one reportable segment and manages a portfolio of in-house brands such as Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, and Ilera Healthcare. TerrAscend also produces and sells products under third-party licensed brands, serving as the exclusive manufacturer and commercialization partner for Wana in Maryland and Cookies in New Jersey, Maryland, and Pennsylvania. Its retail network includes The Apothecarium dispensaries and Cookies Canada in Toronto. The company was incorporated in 2017.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Packaged Foods Homepage ir.terrascend.com
Sector Consumer Defensive IR page ir.terrascend.com
Tags
cannabis cultivation, cannabis processing, cannabis retail, medical cannabis, adult-use cannabis, edibles, vaporizables, concentrates, topicals, tinctures, TerrAscend New Jersey, TerrAscend Maryland, TerrAscend Pennsylvania, TerrAscend California, TerrAscend Ohio, TerrAscend Canada, Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, The Apothecarium, Cookies Canada
Press page —

Metrics

Valuation  
Market cap C$ 135.705M
Market cap (USD) $ 94.864M
P/E -4.66
PEG —
P/BV 1.73
P/S 0.51
P/OCF 4.25
P/FCF 5.43
Dividend yield —
Turnover / mcap —
Returns  
ROE -59.0%
ROI -25.1%
ROIC 6.5%
Profit margin -31.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 266.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 34
Quality score -31.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2024 FY 2023
Revenue 268.078M 250.509M
Net profit -72.67M -86.73M

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Q3 2026 Net Revenue of $68.2 Million, Up 4.8% Year-Over-Year

Q3 2026 Gross Profit Margin of 52.3%, Up 20 Basis Points Year-Over-Year

Q3 2026 Net Cash Provided from Continuing Operations of $8.8 Million, Representing 17.7% Operating Cash Flow Yield1

Q3 2026 Free Cash Flow¹ of $6.1 Million, Representing 14.0% Free Cash Flow Yield1

17th Consecutive Quarter of Positive Cash Flow from Continuing Operations and 13th Consecutive Quarter of Positive Free Cash Flow¹

TORONTO, November 5, 2026 – TerrAscend Corp. (“TerrAscend” or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today reported its financial results for the third quarter ended September 30, 2026. All amounts are expressed in U.S. dollars and are prepared under U.S. Generally Accepted Accounting Principles (GAAP), unless indicated otherwise.

The following financial measures are reported as results from continuing operations unless otherwise noted, due to the Company’s previously stated intention to sell all of its Michigan assets, which are reported as discontinued operations effective as of the second quarter ended June 30, 2025. All historical periods have been restated accordingly.

Multimedia

October 19, 2026 9:00am EDT Download as PDF

TORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its third quarter ended September 30, 2026 on Thursday, November 5, 2026, at 5:00 p.m. Eastern Time. The Company will report its financial results for the third quarter 2026 the same day after market close.

CONFERENCE CALL DETAILS
Date: Thursday, November 5, 2026
Time: 5:00 p.m. Eastern Time
Webcast: https://app.webinar.net/0Gmb21Rzldp
Dial-in Number: 1-888-510-2154
Replay: 1-289-819-1450 or 1-888-660-6345 Available until 12:00 midnight Eastern Time on Thursday, November 19, 2026 Replay Entry Code: 25431 #

About TerrAscend Corp.
TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. On April 23, 2026, the U.S. Department of Justice issued a final rule rescheduling marijuana contained in United States Food and Drug Administration (“FDA”)-approved drug products and marijuana subject to a state medical marijuana license from Schedule I to Schedule III of the Controlled Substances Act (“CSA”), which became effective on April 28, 2026. However, any form of marijuana other than in an FDA-approved drug product or marijuana subject to a state medical marijuana license remains a Schedule I controlled substance under the CSA, and those who handle such material remain subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.

Prompts

TerrAscend Corp. (ticker TSND), listed in United States.

Company History

Date Change Detail
— Former tickers TRSSF

ETFs Holding TerrAscend Corp.

ETF Weight in ETF Shares Market value As of
MSOS 3.35% 56,432,912 $ 21.721M Nov 17, 2026
YOLO 1.91% 1,371,344 $ 527.83K Nov 17, 2026
DFIS 0.00% 60,700 $ 24.685K Nov 12, 2026
DFAX 0.00% 100,200 $ 40.749K Nov 12, 2026
DFIC 0.00% 86,300 $ 35.096K Nov 12, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
TSND Common share — CA tsx — —
TSNDF canonical Common share — US otc 0.44 USD 2025-11-24